Pharmaceuticals & Biotech

1+ hour, 13+ min ago   (657+ words) Children aged 2 to 5 with cystic fibrosis who switched from Trikafta to the newer once-daily drug Alyftrek saw their sweat chloride levels fall further, with about two-thirds reaching the range considered normal. Vertex Pharmaceuticals presented the data as a late-breaking abstract…...

16+ min ago   (178+ words) In recent weeks the results (announced by press release) of 2 major placebo-controlled randomized trials—ZEUS, testing an interleukin-6 (IL-6) blocker vs inflammation, and HORIZON, testing a drug to lower Lp(a), indicated failure to achieve their primary endpoint. Are we maxxed…...

1+ hour, 29+ min ago   (376+ words) The event is hosted by Kennedy’s anti-vaccine group Children’s Health Defense. US Health Secretary Robert F. Kennedy Jr. will deliver a keynote address at an anti-vaccine conference being held in Washington, DC, later this week and hosted by the anti-vaccine…...

3+ hour, 6+ min ago   (71+ words) tradingview.com NVCR: Growth in oncology franchises and global expansion drive profitability and pipeline momentum Disciplined investment and cost controls have reignited GBM growth and enabled global expansion, with strong launches in pancreatic and lung cancer, especially in Japan. Profitability…...

13+ min ago   (325+ words) Parents have every reason to feel confused by the changing conversation around childhood vaccines. Recommendations are being debated nationally and Florida is reconsidering some of its school immunization requirements. Headlines can make it difficult to know what has actually changed…...

2+ hour, 23+ min ago   (875+ words) The government is planning to conduct an intensified measles-rubella catch-up vaccination campaign from the last week of this month amid a growing number of measles infections and deaths across the country. The drive is planned to start on September 26, but…...

10+ hour, 2+ min ago   (415+ words) Written by Valerie Bey | Sept. 14, 2026 From left, Valerie Bey chats with Sheinei Alan, MD, PhD, and director of clinical research at the Inova Adult Sickle Cell Center in Fairfax, Virginia. (Courtesy of Valerie Bey) In recognition of Sickle Cell Disease…...

1+ hour, 33+ min ago   (86+ words) TradingView NTLA: Late-stage gene editing therapies for HAE and TTR advance, with FDA review and strong market prospects The company is advancing in vivo gene editing with late-stage programs for HAE and TTR, expecting FDA approval for its HAE therapy…...

2+ hour, 34+ min ago   (241+ words) Healthcare Headlines: Mergers, Trials, and Regulatory News Devdiscourse Healthcare Headlines: Mergers, Trials, and Regulatory News Healthcare sector sees a flurry of activity with Kimberly-Clark's strategic move to facilitate a major acquisition, Novo Nordisk's rebranding for a market edge, and a…...

7+ hour, 49+ min ago   (726+ words) An experimental immunotherapy given without chemotherapy kept patients with advanced squamous lung cancer alive a median of 18.5 months, compared with 10.0 months for those who received standard chemotherapy, according to updated trial data released Monday by BioNTech and its partner OncoC4. The…...